Table III.
TMOD1 expression levels in the clinical database.
| Stage | Sample name | Relative TMOD1 expression level | Histology | Patient age, years |
|---|---|---|---|---|
| I (n=12) | gsm117626 | 4.27 | Endometrioid carcinoma | >40 |
| gsm152580 | 4.68 | Squamous cell carcinoma, spindle cell type | <40 | |
| gsm152635 | 6.12 | Squamous cell carcinoma | <40 | |
| gsm152667 | 5.09 | Adenocarcinoma | <40 | |
| gsm152719 | 4.47 | Adenocarcinoma | <40 | |
| gsm179853 | 7.02 | Adenosquamous carcinoma | <40 | |
| gsm179907 | 4.49 | Squamous cell carcinoma, non-keratinizing | >40 | |
| gsm179956 | 4.49 | Squamous cell carcinoma, non-keratinizing | <40 | |
| gsm203742 | 4.69 | Squamous cell carcinoma, non-keratinizing | >40 | |
| gsm325835 | 8.46 | Mucinous Adenocarcinoma, endocervical type | <40 | |
| gsm46919 | 5.46 | Squamous cell carcinoma, verrucous | >40 | |
| gsm46942 | 6.01 | Squamous cell carcinoma, non-keratinizing | <40 | |
| II (n=1) | gsm203799 | 4.79 | Squamous cell carcinoma, non-keratinizing | >40 |
| III (n=9) | gsm117576 | 2.00 | Squamous cell carcinoma, keratinizing | <40 |
| gsm152587 | 2.68 | Squamous cell carcinoma | >40 | |
| gsm152723 | 3.66 | Squamous cell carcinoma, keratinizing | >40 | |
| gsm152751 | 0.58 | Squamous cell carcinoma, keratinizing | >40 | |
| gsm152788 | 2.94 | Squamous cell carcinoma | >40 | |
| gsm102527 | 1.49 | Squamous cell carcinoma | >40 | |
| gsm203622 | 5.35 | Adenocarcinoma | >40 | |
| gsm76614 | 1.32 | Squamous cell carcinoma, non-keratinizing | >40 | |
| gsm89050 | 5.30 | Squamous cell carcinoma, non-keratinizing | <40 | |
| IV (n=3) | gsm102481 | 4.83 | Squamous cell carcinoma, non-keratinizing | <40 |
| gsm152787 | 2.83 | Squamous cell carcinoma, non-keratinizing | <40 | |
| gsm152800 | 1.77 | Squamous cell carcinoma | >40 |
TMOD1, tropomodulin-1; gsm: Gene Expression Omnibus database sample.